Stocks to watch Monday: Mattel, Biogen Idec MarketWatch More good news for Biogen Idec Inc.: The company and Abbott Laboratories Inc. /quotes/zigman/216393/quotes/nls/abt ABT -0.76% on Saturday presented positive data from a trial to evaluate an investigational compound known as daclizumab high-yield ... |
